Correlation Between Mineralys Therapeutics, and Avalo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Avalo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Avalo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Avalo Therapeutics, you can compare the effects of market volatilities on Mineralys Therapeutics, and Avalo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Avalo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Avalo Therapeutics.
Diversification Opportunities for Mineralys Therapeutics, and Avalo Therapeutics
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Mineralys and Avalo is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Avalo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avalo Therapeutics and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Avalo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avalo Therapeutics has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Avalo Therapeutics go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Avalo Therapeutics
Given the investment horizon of 90 days Mineralys Therapeutics, is expected to generate 2.37 times less return on investment than Avalo Therapeutics. But when comparing it to its historical volatility, Mineralys Therapeutics, Common is 4.7 times less risky than Avalo Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Avalo Therapeutics is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 124,800 in Avalo Therapeutics on August 30, 2024 and sell it today you would lose (123,845) from holding Avalo Therapeutics or give up 99.23% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 91.72% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Avalo Therapeutics
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Avalo Therapeutics |
Mineralys Therapeutics, and Avalo Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Avalo Therapeutics
The main advantage of trading using opposite Mineralys Therapeutics, and Avalo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Avalo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avalo Therapeutics will offset losses from the drop in Avalo Therapeutics' long position.| Mineralys Therapeutics, vs. Ultra Clean Holdings | Mineralys Therapeutics, vs. Playtika Holding Corp | Mineralys Therapeutics, vs. Helmerich and Payne | Mineralys Therapeutics, vs. Capital Clean Energy |
| Avalo Therapeutics vs. AnaptysBio | Avalo Therapeutics vs. Arcellx | Avalo Therapeutics vs. Structure Therapeutics American | Avalo Therapeutics vs. Aerovate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |